title: Bladder cancer.
abstract: Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.
authors.affiliation: Vanderbilt-Ingram Cancer Center.
authors.forename: Peter E
authors.initials: PE
authors.lastname: Clark
authors.forename: Neeraj
authors.initials: N
authors.lastname: Agarwal
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Biagioli
authors.forename: Mario A
authors.initials: MA
authors.lastname: Eisenberger
authors.forename: Richard E
authors.initials: RE
authors.lastname: Greenberg
authors.forename: Harry W
authors.initials: HW
authors.lastname: Herr
authors.forename: Brant A
authors.initials: BA
authors.lastname: Inman
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Kuban
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Kuzel
authors.forename: Subodh M
authors.initials: SM
authors.lastname: Lele
authors.forename: Jeff
authors.initials: J
authors.lastname: Michalski
authors.forename: Lance C
authors.initials: LC
authors.lastname: Pagliaro
authors.forename: Sumanta K
authors.initials: SK
authors.lastname: Pal
authors.forename: Anthony
authors.initials: A
authors.lastname: Patterson
authors.forename: Elizabeth R
authors.initials: ER
authors.lastname: Plimack
authors.forename: Kamal S
authors.initials: KS
authors.lastname: Pohar
authors.forename: Michael P
authors.initials: MP
authors.lastname: Porter
authors.forename: Jerome P
authors.initials: JP
authors.lastname: Richie
authors.forename: Wade J
authors.initials: WJ
authors.lastname: Sexton
authors.forename: William U
authors.initials: WU
authors.lastname: Shipley
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Small
authors.forename: Philippe E
authors.initials: PE
authors.lastname: Spiess
authors.forename: Donald L
authors.initials: DL
authors.lastname: Trump
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Wile
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Wilson
authors.forename: Mary
authors.initials: M
authors.lastname: Dwyer
authors.forename: Maria
authors.initials: M
authors.lastname: Ho
mesh_terms: D000283:Administration, Intravesical; D000465:Algorithms; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D015653:Cystectomy / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D019042:Muscle Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000556:secondary; D020360:Neoadjuvant Therapy / Q000379:methods; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging / Q000379:methods; D059351:Organ Sparing Treatments / Q000379:methods; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D019459:Urothelium / Q000473:pathology